The CDH16 gene gives instructions for a cell joining protein used mainly in the kidneys, where it helps the cells lining kidney tubules stay connected and organized. This supports normal kidney structure and helps the body handle water and minerals as urine is formed. If the CDH16 gene does not work properly, kidney tubules may not develop or function as they should, which can contribute to kidney problems.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells can use to make molecules or regulate processes in the body. Some genes provide the information needed to produce proteins, the parts of cells that do the work. Others mainly help control when certain processes happen, where they occur, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. If you want to explore this topic more closely, you can learn more in the LearnHub.
Overview
CDH16Gene function
What if the gene works
The CDH16 gene helps kidney tubule cells stick together. This supports the structure and routine work of the kidney tubes that help make urine.
Risk
What if the gene does not work
Changes in the CDH16 gene can weaken how kidney tubule cells stick to each other and stay organized. Milder variants may slightly reduce this cell to cell adhesion, while more severe variants can disrupt the protein more fully.
Treatment
What does that mean for your treatment
No CDH16-specific treatment or drug selection approach is currently established for people with a pathogenic variant in the CDH16 gene. In research settings, CDH16 is being studied mainly as a biomarker, especially in some kidney and thyroid tumors, rather than as a direct treatment target.
Gene function
What if the gene works
In your kidneys, the CDH16 gene helps nearby tubule cells stay connected and organized. Its protein sits at the cell surface and forms part of the holding system that keeps the kidney lining in place. This steady contact supports the normal structure of kidney tubules as they handle water and salts.
The protein made from the CDH16 gene helps neighboring kidney tubule cells attach to each other. This contact depends on calcium and keeps the cell layer connected as fluid moves through the tubules.
By helping cells hold onto one another, the CDH16 gene supports the tidy tube shape of kidney tubules. This cell to cell grip is a core part of how the CDH16 gene works in kidney tissue.
The CDH16 protein helps kidney lining cells stay in an organized sheet instead of acting as isolated cells. That orderly arrangement supports day to day kidney handling of water and dissolved salts.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help explain normal differences between people, including appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the CDH16 gene can alter how the cadherin-16 protein folds, stays stable, reaches the cell surface, or attaches to nearby cells. In understanding how CDH16 gene variants affect protein function, milder variants may only partly weaken the protein, while more severe variants can shorten it, misdirect it inside the cell, or stop it from being made at all. These differences can lead to a spectrum of reduced cell-adhesion activity.
How variants are linked to conditions
The CDH16 gene does not yet have a broadly confirmed link to a specific health condition, though research on CDH16 gene variants and health conditions is still developing. If you have a confirmed CDH16-related finding, your doctor or genetic counselor can explain what it may mean for you and your family.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are widely found in the general population. Most have no direct impact on health and simply represent natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental influences play a role. In some instances, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to the CDH16 gene. Anyone with concerns about their personal risk or family history can speak with a doctor or genetic counselor.
Inheritance of CDH16 variants
There is not yet a broadly confirmed Mendelian pattern for the inheritance of CDH16 gene variants tied to a specific human condition, and this picture may become clearer as research develops. For families looking into the inheritance of CDH16 gene variants, CDH16 is located on chromosome 16, which is an autosome. That means each person inherits one copy of the CDH16 gene from each parent.
What does my CDH16 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific condition for CDH16, and understanding may change as research grows. If you have a specific CDH16 result and want to know what it could mean for relatives, a doctor or genetic counselor can help put it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the CDH16 gene, CDH16 genetic testing uses a blood or saliva sample. A lab reads the DNA sequence and compares it with the usual sequence to identify variants. Results may show no variant, a known pathogenic variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
There isn't yet a broadly established, CDH16-specific clinical reason for testing. Decisions about genetic testing are usually based on the bigger picture, including personal health, family history, and whether a doctor or genetic counselor thinks a broader kidney- or cancer-related gene test would be helpful.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body works. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best interpreted alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in a person’s DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in some people.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can shape a person’s response to medicines. By studying links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medications, genes influence both how strongly a drug works and how the body processes it. Understanding this can support treatment decisions that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the CDH16 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so concerns about side effects, new symptoms, or whether a treatment is working are best discussed with your doctor.
History
The CDH16 gene entered the medical literature in the 1990s, when researchers studying kidney tissue identified a cadherin that was present mainly in kidney tubules. Initially understood only through visible tissue patterns, later recognized as tied to a specific gene, it was first known by names such as kidney specific cadherin or KSP cadherin. From these first observations, research expanded steadily, and CDH16 became a useful marker in studies of kidney development and in some pathology work comparing kidney and thyroid tissues. Over time, descriptions became more precise as gene mapping placed CDH16 on chromosome 16 and linked it to a broader cadherin family. The way this gene was viewed has shifted over time, from a tissue marker to part of a clearer picture of specialized kidney cell identity.